ODDO BHF Asset Management’s Cidara Therapeutics CDTX Stock Holding History

ODDO BHF Asset Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-142,500	Closed	-$31.5M	–	281
2025 Q4	$31.5M	Buy	+142,500	New	+$23M	1.18%	20

ODDO BHF Asset Management's CDTX Position: Q1 2026 in Review

ODDO BHF Asset Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 142,500 shares — an estimated $31.5M sold.

ODDO BHF Asset Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $31.5M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

ODDO BHF Asset Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
ODDO BHF Asset Management sold 142,500 Cidara Therapeutics shares in Q1 2026, an estimated $31.5M.
ODDO BHF Asset Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
ODDO BHF Asset Management's Cidara Therapeutics position peaked at $31.5M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on ODDO BHF Asset Management's 13F filing for Q1 2026, filed 18 May 2026.